Live Quote · NASDAQAPTOHealthcare· Biotechnology

Aptose Biosciences Inc.

$1.71 100.00%(+$1.71)
TickerSpark Score
38/100
Weak
100
Valuation
20
Profitability
15
Growth
24
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a APTO research report →

52-Week Range1% of range
Low
$1.10
Current
$1.71
High
$43.19
Company Overviewwww.aptose.com

About the company

Aptose Biosciences Inc. operates as a clinical-stage biopharmaceutical enterprise, dedicated to discovering and advancing personalized therapeutic solutions to address critical unmet medical needs within the field of oncology, primarily focusing on the United States market. Its active clinical pipeline features several promising candidates.

CEO
William G. Rice
IPO
1992
Employees
35
HQ
Toronto, ON, CA

Price Chart

-95.25% · this period
$36.90$19.30$1.71Apr 30Oct 29Feb 10
Valuation
Market Cap
$4.36M
P/E
0.79
P/S
0.00
P/B
-0.13
EV/EBITDA
-2.33
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
-23.18%
ROIC
-1252.52%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$0 · 100.00%
EPS
$-10.41 · -81.68%
Op Income
$0
FCF YoY
100.00%
Performance & Tape
52W High
$43.19
52W Low
$1.10
50D MA
$3.93
200D MA
$9.25
Beta
1.13
Avg Volume
223.28K

Get TickerSpark's AI analysis on APTO

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 30, 26Seizinger Bernd R.sell17,000
Jun 30, 26Seizinger Bernd R.sell3,333
Jun 30, 26Seizinger Bernd R.sell100,000
Jun 30, 26Seizinger Bernd R.sell50,000
Jun 30, 26Whitehead Warrensell33
Jun 30, 26Whitehead Warrensell3,333
Jun 30, 26Whitehead Warrensell100,000
Jun 30, 26Whitehead Warrensell50,000
Jun 30, 26Whitehead Warrensell50,000
Jun 30, 26Whitehead Warrensell50,000
Coverage · APTO

Our APTO coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on APTO yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate APTO report →
Internal Compare

Similar companies

Peers in the same neighborhood.